Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02796196
Other study ID # IRB-35379
Secondary ID NCI-2016-00737VA
Status Completed
Phase
First received
Last updated
Start date May 2016
Est. completion date March 1, 2017

Study information

Verified date November 2018
Source Stanford University
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

This research trial studies prescribed physical activity in improving sleep and physical performance in patients undergoing stem cell transplant. A wearable physical activity monitor can be used to record minutes of activity and sleep. Gathering data over time using a physical activity monitor may help doctors learn if prescribed physical activity helps improve sleep and physical performance in patients undergoing stem cell transplant.


Description:

PRIMARY OBJECTIVES:

I. Evaluate whether prescribed physical activity, as part of standard care, improves sleep and functional outcomes in hematopoietic cell transplantation (HCT) (stem cell transplantation) patients during a typical 30-day hospitalization period.

OUTLINE:

Data including demographics, type of HCT (e.g., allogeneic or autologous), preexisting physical conditions (e.g., chronic joint injury), chronic renal failure (CRF), steroid use data, Eastern Cooperative Oncology Group (ECOG) and Karnofsky performance status (KPS) scores are collected from patients' medical charts at time of enrollment. Patients are prescribed participation in a primarily self-directed physical activity program which encourages them to spend 6 hours out of bed daily and to perform 30 minutes of light-to-moderate daily aerobic activity. Patients who are able to maintain independent mobility undergo physical therapist assessment 2 times a week until hospital discharge. Patients wear a physical activity monitoring device and daily activity and sleep data are collected continuously during hospital length of stay (LOS).


Recruitment information / eligibility

Status Completed
Enrollment 75
Est. completion date March 1, 2017
Est. primary completion date March 2017
Accepts healthy volunteers No
Gender All
Age group N/A and older
Eligibility Inclusion Criteria:

- Admitted to Stanford Hospital for HCT

- Able to provide informed consent

- Speaks language supported by interpretative services

- Able to operate and take care of a physical activity monitor

Exclusion Criteria:

- Does not meet inclusion criteria

- Unable to wear a physical activity monitor throughout hospital stay

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Medical Chart Review
Review of medical chart
Device:
Monitoring Device
Wearable physical activity monitoring device
Procedure:
Physical Therapy
Undergo primarily self-directed physical therapy

Locations

Country Name City State
United States Stanford University, School of Medicine Palo Alto California

Sponsors (1)

Lead Sponsor Collaborator
Stanford University

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary ECOG performance scores Will focus on trends in scores between patients with different durations of activity and sleep. Results, from both descriptive and inferential analyses, will be presented in table and/or graphical format. At baseline
Primary KPS performance scores Will focus on trends in scores between patients with different durations of activity and sleep. Results, from both descriptive and inferential analyses, will be presented in table and/or graphical format. At baseline
Primary Minutes of aerobic activity per day Will use interval-censored regression to estimate distributions of activity from one day to the next. This repeated-measures analysis with a polynomial model will generate average curves for activity, each spanning average LOS (i.e., activity duration plotted on day one, day two, day three, etc.). Will also run diagnostics to verify the assumptions of a linear model (e.g., statistical independence of observations and lack of undue influence of outliers on model fit). Up to time of hospital discharge, or 29 days
Primary Minutes of sleep per day Will use interval-censored regression to estimate distributions of sleep from one day to the next. This repeated-measures analysis with a polynomial model will generate average curves for sleep, each spanning average LOS (i.e., sleep duration plotted on day one, day two, day three, etc.). Will use multiple linear regressions to control for potential confounders in predicting sleep duration. Will also run diagnostics to verify the assumptions of a linear model (e.g., statistical independence of observations and lack of undue influence of outliers on model fit). Up to time of hospital discharge, or 29 days
See also
  Status Clinical Trial Phase
Completed NCT03021681 - An Exploratory Study on the Treatment of Chronic Obstructive Pulmonary Disease With Autologous Bronchial Basal Cell Transplantation N/A
Recruiting NCT02890953 - Efficacy and Safety of Pneumostem® for IVH in Premature Infants (Phase 2a) Phase 2
Withdrawn NCT04428918 - Biospecimen Procurement for Immunological Landscape Studies Following Hematopoietic Cell Transplantation